Ipamorelin

Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist with high specificity for stimulating endogenous growth hormone release. Noted for its minimal off-target effects on prolactin and cortisol, ipamorelin provides a targeted approach for research into growth hormone modulation, aging, and metabolic function. Its pentapeptide structure facilitates potent stimulation of the growth hormone secretagogue receptor (GHS-R) without significant desensitization, supporting its utility in chronic experimental designs. Ipamorelin’s favorable safety and pharmacokinetic profiles make it a preferred agent in the investigation of endocrine therapies and regenerative medicine models.

This product is intended solely for laboratory research use and is not approved for human or veterinary applications, diagnostic procedures, therapeutic uses, or consumption. All products are sold under the condition that they will be handled exclusively by qualified individuals familiar with their use and potential risks. Any application of this material in humans or animals for therapeutic or diagnostic purposes must comply with the regulations established in 21 CFR 312 and 21 CFR 600.